{
    "2021-10-26": [
        [
            {
                "time": "2021-10-26",
                "original_text": "债券重大事件2021年10月26日星期二",
                "features": {
                    "keywords": [
                        "债券",
                        "重大事件"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "海外信用评级汇总2021年10月26日星期二",
                "features": {
                    "keywords": [
                        "海外",
                        "信用评级",
                        "汇总"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "“金句专业户”焦巍又反思：坦言自身投资模式现阶段或落后，也要减少噪音干扰，增加长期绝对回报",
                "features": {
                    "keywords": [
                        "焦巍",
                        "反思",
                        "投资模式",
                        "长期回报"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "医药生物行业双周报：行业估值合理 择优布局优质标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业估值",
                        "优质标的"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "惠誉：上调药明康德长期发行人违约评级至“BBB”，展望“稳定”",
                "features": {
                    "keywords": [
                        "惠誉",
                        "药明康德",
                        "评级",
                        "上调"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "干货！2021年中国医药研发外包(CRO)行业龙头企业分析——康龙化成：被低估的CRO龙头",
                "features": {
                    "keywords": [
                        "医药研发",
                        "CRO",
                        "康龙化成",
                        "龙头企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "医药行业一周观察：Atea新冠药二期未达终点，医药创新道虽阻行不辍",
                "features": {
                    "keywords": [
                        "医药行业",
                        "Atea",
                        "新冠药",
                        "创新"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "王宗合三季报：加仓山西汾酒、药明康德、福斯特、三峡能源",
                "features": {
                    "keywords": [
                        "王宗合",
                        "三季报",
                        "加仓",
                        "山西汾酒",
                        "药明康德",
                        "福斯特",
                        "三峡能源"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "药明康德三季度成嘉实策略混合基金重仓股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "嘉实策略",
                        "混合基金",
                        "重仓股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-26",
                "original_text": "今日下午3点！定量整体放射性自显影（QWBA）平台加速新药研发",
                "features": {
                    "keywords": [
                        "定量整体放射性自显影",
                        "QWBA",
                        "新药研发"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}